肠易激综合症。

Current review of pain Pub Date : 2000-01-01 DOI:10.1007/s11916-000-0010-x

S M Turner, J E Stewart, J J Alexopulos, J S Hill

{"title":"肠易激综合症。","authors":"S M Turner, J E Stewart, J J Alexopulos, J S Hill","doi":"10.1007/s11916-000-0010-x","DOIUrl":null,"url":null,"abstract":"Within the literature, it appears evident that neither a univariate etiologic model nor a single-agent treatment approach is sufficient to address the many diagnostic, assessment, and therapeutic challenges posed by irritable bowel syndrome (IBS). Various scientific advances have been made over the past 5 years, particularly in the areas of nonpharmacologic management of IBS. However, further collaboration between scientists and clinicians from multiple disciplines is strongly encouraged.","PeriodicalId":80271,"journal":{"name":"Current review of pain","volume":"4 1","pages":"54-9"},"PeriodicalIF":0.0000,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11916-000-0010-x","citationCount":"1","resultStr":"{\"title\":\"Irritable bowel syndrome.\",\"authors\":\"S M Turner, J E Stewart, J J Alexopulos, J S Hill\",\"doi\":\"10.1007/s11916-000-0010-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Within the literature, it appears evident that neither a univariate etiologic model nor a single-agent treatment approach is sufficient to address the many diagnostic, assessment, and therapeutic challenges posed by irritable bowel syndrome (IBS). Various scientific advances have been made over the past 5 years, particularly in the areas of nonpharmacologic management of IBS. However, further collaboration between scientists and clinicians from multiple disciplines is strongly encouraged.\",\"PeriodicalId\":80271,\"journal\":{\"name\":\"Current review of pain\",\"volume\":\"4 1\",\"pages\":\"54-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2000-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1007/s11916-000-0010-x\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current review of pain\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s11916-000-0010-x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current review of pain","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s11916-000-0010-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

摘要

在文献中，很明显，单变量病因模型和单药治疗方法都不足以解决肠易激综合征(IBS)带来的许多诊断、评估和治疗挑战。在过去的5年中，特别是在肠易激综合征的非药物治疗领域取得了各种各样的科学进展。然而，强烈鼓励来自多学科的科学家和临床医生之间的进一步合作。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Irritable bowel syndrome.

Within the literature, it appears evident that neither a univariate etiologic model nor a single-agent treatment approach is sufficient to address the many diagnostic, assessment, and therapeutic challenges posed by irritable bowel syndrome (IBS). Various scientific advances have been made over the past 5 years, particularly in the areas of nonpharmacologic management of IBS. However, further collaboration between scientists and clinicians from multiple disciplines is strongly encouraged.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Current review of pain

自引率

0.00%

发文量

期刊最新文献

Is the term "pain disorder" a valid diagnosis? Epidemic occupational pseudo-illness: the plague of acronyms. The debate over chronic pain continues Controversies surrounding reflex sympathetic dystrophy: a review article. Reflex sympathetic dystrophy: a sympathetically mediated pain syndrome or not?